Smart ring maker Oura postponed its planned $2.2 billion initial public offering on Tuesday, citing "market uncertainty" — the latest productive business frozen out of public capital markets by the Federal Reserve's rate-hiking campaign.
The delay matters because it exposes who actually pays when central planners at the Fed manipulate borrowing costs: companies that make real products, employ real workers, and serve real customers. Oura is profitable. It expects 90% revenue growth this fiscal year. It has 5.7 million paid members. By any honest measure, the business is succeeding. The IPO window is slamming shut anyway — not because the company failed, but because the Fed's resumption of rate hikes and the resulting surge in bond yields have made public markets hostile territory for anyone trying to raise money.
Oura had planned to sell 50 million shares at $40 to $44, which would have valued the company at roughly $13.5 billion at the midpoint, according to The Guardian. Notably, nearly three-quarters of those shares were being sold by current shareholders — meaning the IPO was partly an insider cash-out, not purely a capital raise. CEO Tom Hale put the best face on the retreat: "We aim to deliver an extraordinary IPO for our employees and investors and we have the luxury of choosing our moment," he said in a statement reported by CNBC. "In the meantime, we will execute against the opportunities ahead."
Oura isn't alone. Reuters reported the company joins "a growing list of prospective issuers pulling back as surging bond yields and higher interest rates weigh on markets." Holtec Nuclear withdrew its IPO earlier this month, specifically citing "rising energy costs, elevated global trade tensions, ongoing military conflicts, and mounting inflation fears that have driven the central banks of major economies (EU, Japan and US) to raise their benchmark rates," as CNBC reported. Research firm Renaissance Capital told The Guardian the IPO market had a solid start to the year but "tailed off in the third quarter," driven by AI spending concerns, the Fed's rate hikes, and surging bond yields making borrowing more expensive.
The pattern is plain: the Fed's rate hikes were sold as inflation medicine. What they're delivering is capital market paralysis. Oura formally launched its IPO plans on September 21 and pulled the plug eight days later. That's not a company reconsidering its strategy — that's a market that stopped functioning.
Oura has the balance sheet to wait. The question is how many businesses that aren't as well-positioned — companies that need public capital to expand or survive — are quietly shelving plans because the Fed made it too expensive to access the market. The IPO window doesn't stay closed forever. The businesses that die waiting for it to reopen don't come back at all.
